Mediclinic International (Mediclinic International) COGS-to-Revenue : 0.86 (As of Sep. 2022)

View and export this data going back to 2016. Start your Free Trial

What is Mediclinic International COGS-to-Revenue?

Mediclinic International's Cost of Goods Sold for the six months ended in Sep. 2022 was $1,678 Mil. Its Revenue for the six months ended in Sep. 2022 was $1,960 Mil.

Mediclinic International's COGS to Revenue for the six months ended in Sep. 2022 was 0.86.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Mediclinic International's Gross Margin % for the six months ended in Sep. 2022 was 14.38%.

Mediclinic International COGS-to-Revenue Historical Data

The historical data trend for Mediclinic International's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mediclinic International COGS-to-Revenue Chart

Mediclinic International Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

COGS-to-Revenue

Get a 7-Day Free Trial

0.62

0.64

0.82

0.86

0.84

Mediclinic International Semi-Annual Data
	Mar13	Sep13	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22
COGS-to-Revenue	Get a 7-Day Free Trial															0.88	0.84	0.85	0.84	0.86

Mediclinic International COGS-to-Revenue Calculation

Mediclinic International's COGS to Revenue for the fiscal year that ended in Mar. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	3594.203	/	4259.552
	=	0.84

Mediclinic International's COGS to Revenue for the quarter that ended in Sep. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1678.369	/	1960.362
	=	0.86

Mediclinic International (OTCPK:ANHGY) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Mediclinic International's Gross Margin % for the six months ended in Sep. 2022 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	1678.369 / 1960.362
	=	14.38 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Mediclinic International COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Mediclinic International's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Mediclinic International (Mediclinic International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mediclinic International PLC (OTCPK:ANHGY) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ

Website

https://www.mediclinic.com

Mediclinic International PLC is a UK based international private healthcare group. It is engaged in offering acute care, specialist-orientated and multi-disciplinary healthcare services, by operating many hospitals and clinics. The geographic operating segments of the company are Mediclinic Southern Africa, Mediclinic Switzerland, and Mediclinic Middle East. It derives the majority of the revenue from the Switzerland segment. The other non-operating segments of the company are the United Kingdom and Corporate. The group's operations are carried out under the Mediclinic and Hirslanden brand.